Wafik S El-Deiry, MD, PhD, FACP
Lab Personnel, January 2012
- HHMI 1995-2004
- NIH 1997-present
- AACR 2005-2007
- ACS 2009-present
Quest For Answers
"We're trying to understand how cancer cells die, how they're affected by chemotherapy or newer agents, why they become resistant to certain treatments and how to develop strategies to reverse the resistance," says Wafik El-Deiry, MD, PhD, chief of hematology/oncology at Penn State Hershey Medical Center
View entire PDF article
Kuwait Prize In Applied Sciences
Dr. El-Deiry was recognized for his work on tumor suppressor genes including p53 and TRAIL, and mechanisms that determine cancer therapeutic response. Dr. El-Deiry was recognized for developing new strategies targeting cell death for cancer therapy.
Read full article from Cancer Biology & Therapy
Small Molecule Drug Drives Cancer Cells to Suicide
Cancer researchers have pinned down a molecule that can kick-start the body's own tumour-destroying systems, triggering cell death in cancerous but not healthy tissue in mice.
Read full article from Nature News